AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Nuwellis, a medical technology company, announced that a leading Northeastern US children's hospital has initiated an Aquadex Ultrafiltration Program. Pediatric nephrology and cardiology teams across the country are adopting the therapy due to its minimal extracorporeal volume requirement and reliability in managing fluid-sensitive patients, driving steady growth in Nuwellis' expanding pediatric market. Children's hospitals are integrating Aquadex into care pathways for complex cardiac, cardio-renal, and critical care cases.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet